| T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial DW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, ... The Lancet 385 (9967), 517-528, 2015 | 3350 | 2015 |
| Current concepts in the diagnosis and management of cytokine release syndrome DW Lee, R Gardner, DL Porter, CU Louis, N Ahmed, M Jensen, SA Grupp, ... Blood, The Journal of the American Society of Hematology 124 (2), 188-195, 2014 | 3044 | 2014 |
| Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1 PF Robbins, RA Morgan, SA Feldman, JC Yang, RM Sherry, ME Dudley, ... Journal of Clinical Oncology 29 (7), 917-924, 2011 | 1998 | 2011 |
| 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors AH Long, WM Haso, JF Shern, KM Wanhainen, M Murgai, M Ingaramo, ... Nature medicine 21 (6), 581-590, 2015 | 1791 | 2015 |
| CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy TJ Fry, NN Shah, RJ Orentas, M Stetler-Stevenson, CM Yuan, ... Nature medicine 24 (1), 20-28, 2018 | 1372 | 2018 |
| Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy CL Mackall, TA Fleisher, MR Brown, MP Andrich, CC Chen, IM Feuerstein, ... New England Journal of Medicine 332 (3), 143-149, 1995 | 1291 | 1995 |
| Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy E Sotillo, DM Barrett, KL Black, A Bagashev, D Oldridge, G Wu, ... Cancer discovery 5 (12), 1282-1295, 2015 | 1285 | 2015 |
| Tumor antigen escape from CAR T-cell therapy RG Majzner, CL Mackall Cancer discovery 8 (10), 1219-1226, 2018 | 970 | 2018 |
| Disruption of CXCR2-mediated MDSC tumor trafficking enhances anti-PD1 efficacy SL Highfill, Y Cui, AJ Giles, JP Smith, H Zhang, E Morse, RN Kaplan, ... Science translational medicine 6 (237), 237ra67-237ra67, 2014 | 782 | 2014 |
| The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance TJ Fry, CL Mackall The Journal of Immunology 174 (11), 6571-6576, 2005 | 728 | 2005 |
| c-Jun overexpression in CAR T cells induces exhaustion resistance RC Lynn, EW Weber, E Sotillo, D Gennert, P Xu, Z Good, H Anbunathan, ... Nature 576 (7786), 293-300, 2019 | 722 | 2019 |
| Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia W Haso, DW Lee, NN Shah, M Stetler-Stevenson, CM Yuan, IH Pastan, ... Blood, The Journal of the American Society of Hematology 121 (7), 1165-1174, 2013 | 701 | 2013 |
| Harnessing the biology of IL-7 for therapeutic application CL Mackall, TJ Fry, RE Gress Nature Reviews Immunology 11 (5), 330-342, 2011 | 663 | 2011 |
| Interleukin-7: from bench to clinic TJ Fry, CL Mackall Blood, The Journal of the American Society of Hematology 99 (11), 3892-3904, 2002 | 652 | 2002 |
| GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas RG Majzner, S Ramakrishna, KW Yeom, S Patel, H Chinnasamy, ... Nature 603 (7903), 934-941, 2022 | 602 | 2022 |
| Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets C Sportès, FT Hakim, SA Memon, H Zhang, KS Chua, MR Brown, ... Journal of Experimental Medicine 205 (7), 1701-1714, 2008 | 569 | 2008 |
| CAR T cells targeting B7-H3, a pan-cancer antigen, demonstrate potent preclinical activity against pediatric solid tumors and brain tumors RG Majzner, JL Theruvath, A Nellan, S Heitzeneder, Y Cui, CW Mount, ... Clinical Cancer Research 25 (8), 2560-2574, 2019 | 561 | 2019 |
| Clinical lessons learned from the first leg of the CAR T cell journey RG Majzner, CL Mackall Nature medicine 25 (9), 1341-1355, 2019 | 551 | 2019 |
| A potential role for interleukin-7 in T-cell homeostasis TJ Fry, E Connick, J Falloon, MM Lederman, DJ Liewehr, J Spritzler, ... Blood, The Journal of the American Society of Hematology 97 (10), 2983-2990, 2001 | 544 | 2001 |
| IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells SA Rosenberg, C Sportès, M Ahmadzadeh, TJ Fry, LT Ngo, SL Schwarz, ... Journal of immunotherapy 29 (3), 313-319, 2006 | 519 | 2006 |